Evidence map›Paper›PMID 42135353›Full record

ArticleScientific reports2026

Assessing post-cold challenge recovery of thermography as a potential outcome measure in trials of SSc-related Raynaud's phenomenon.

Abigail Aika Ndosi, Graham Dinsdale, Joanne Manning, Melissa Mandzuk, Sarah Wilkinson, Ariane L Herrick, Andrea K Murray

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abigail Aika NdosiScleroderma and Raynaud's Research Group, Centre for Musculoskeletal Research, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
Graham DinsdaleScleroderma and Raynaud's Research Group, Centre for Musculoskeletal Research, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
Joanne ManningScleroderma and Raynaud's Research Group, Centre for Musculoskeletal Research, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
Melissa MandzukDepartment of Rheumatology, Salford Care Organisation, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Sarah WilkinsonScleroderma and Raynaud's Research Group, Centre for Musculoskeletal Research, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
Ariane L HerrickScleroderma and Raynaud's Research Group, Centre for Musculoskeletal Research, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
Andrea K MurrayScleroderma and Raynaud's Research Group, Centre for Musculoskeletal Research, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK. andrea.murray@manchester.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Improved new medications for systemic sclerosis-related Raynaud's phenomenon (SSc-RP) are badly needed and better objective outcomes are required to enable this. Thermography imaging of hand cold-challenge offers potential as an outcome measure. To ensure standardisation between pre- and post-dose cold challenge assessments, it is important to understand the length of time required for patients to recover back to baseline finger temperatures after initial cold challenge. The aim of this study was to determine whether patients with SSc-RP would recover baseline finger temperatures within a 2-h period. Patients with SSc-RP underwent cold-challenge alongside thermography-imaged baseline and post-cold challenge recovery for 2 h. Twenty patients were recruited, eight (40%) had all eight fingers recover to baseline within 2 h, 13 (65%) had more than one finger recover. The median (IQR) time to maximum temperature was 48.43 (33.58-69.38) minutes. This study indicates that most patients will have one or more fingers recover within an hour. Even in those with established SSc it is reasonable to repeat cold challenge with a minimum one-hour interval in clinical trials, enabling pre- and post-dose cold challenges on the same day.

Indexed as

Cold TemperatureRaynaud DiseaseScleroderma, SystemicThermographyAgedFemaleFingersHumansMaleMiddle AgedOutcome Assessment, Health CareSkin TemperatureClinical trials outcome measuresFeasibilityRaynaud’s phenomenonSclerodermaThermal imaging

Identifiers

PMID42135353
PMCPMC13369364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.